Vascular endothelial growth factor trap-eye (Aflibercept) for the management of diabetic macular edema

Diabetic retinopathy (DR) is the most common cause of visual loss among working age individuals. Diabetic macular edema (DME) is an important complication of DR that affects around one third of the patients with DR. Several treatments have been approved for DME ranging from blood pressure and glycem...

Full description

Saved in:
Bibliographic Details
Main Authors: Moradi, Ahmadreza, Sepah, Yasir Jamal, Sadiq, Mohammad Ali, Nasir, Humzah, Kherani, Salima, Sophie, Raafay, Do, Diana V, Nguyen, Quan Dong
Format: Artigo
Language:Inglês
Published: Baishideng Publishing Group Co., Limited 2013
Subjects:
Topic Highlight
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3874490/
https://ncbi.nlm.nih.gov/pubmed/24379921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4239/wjd.v4.i6.303
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items